The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Common cold and resistance?

Mar 27, 2009

If one is taking the prescribed HIV medications with perfect adherence, during an acute viral infection such as common cold would there be a risk of developing resistance since viral infections or vaccinations would increase the patient's viral load?? If yes, is the risk higher in those who have recently started HAART and yet to become undetectable? Thanks much for your valuable opinion.

Response from Dr. Young

Hello and thanks for your interesting question.

There's been a number of studies that have looked at the effect of viral load blips and the risk of drug resistance. None that I'm aware of have indicated that this is a problem.

So, while getting a cold is never good news, here the good news is that other than transiently increasing the HIV viral load (and causing nerves to be on edge sometimes), there's no need to worry about risk of treatment failure.

Be well, BY

Preferred Time Schedule w/ rayataz/truvada/norvir?
wet kiss

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint